Ceylon Cinnamon
300 mg of 10:1 Ceylon cinnamon extract — equivalent to 3,000 mg of raw bark — the insulin sensitizer that reduces postprandial glucose spikes, supports AMPK activation, and protects cognitive performance from the blood sugar volatility that degrades sustained attention and working memory.
Primacy Research
What Ceylon Cinnamon Does For You
Glucose Spike Flattening
Inhibits alpha-amylase and alpha-glucosidase enzymes, slowing carbohydrate digestion and blunting postprandial glucose spikes at the source — delivering steadier fuel to the brain during peak performance hours.
AMPK Activation
Activates AMP-activated protein kinase — the cellular energy sensor that drives GLUT4 translocation for insulin-independent glucose uptake, mimicking an exercise-like metabolic state.
Insulin Receptor Sensitization
Enhances PI3K/Akt signaling downstream of the insulin receptor, reducing the insulin required for glucose clearance and narrowing the glycemic volatility window that impairs sustained attention.
Coumarin-Safe Daily Use
Ceylon cinnamon contains approximately 250x less coumarin than Cassia cinnamon, enabling sustained daily supplementation at effective doses without the hepatotoxic risk that limits Cassia intake.
Antioxidant + Anti-AGE Protection
Polyphenols scavenge free radicals and reduce advanced glycation end product (AGE) formation generated by blood sugar spikes — protecting neurons and blood vessels from glycation damage.
Blood Sugar Volatility Is a Cognitive Performance Tax
The brain runs almost exclusively on glucose, consuming approximately 120 g/day — 20% of total body glucose production. But it’s not total glucose that determines cognitive performance: it’s glucose stability. Postprandial spikes followed by reactive dips create the blood sugar volatility that impairs working memory, sustained attention, and processing speed. Modern diets with high glycemic loads create 2–3 hour cycles of hyperglycemia and relative hypoglycemia — turning cognitive performance into a rollercoaster rather than a steady output.
Postprandial Cognitive Dips
Reactive hypoglycemia following high-glycemic meals reduces cerebral glucose availability, impairing hippocampal function and prefrontal cortex performance. Studies show measurable degradation in sustained attention and working memory 90–120 minutes after high-glycemic meals — the exact window where morning cognitive work occurs after breakfast.
Brain Insulin Resistance
Chronic glycemic volatility degrades central insulin signaling. Brain insulin resistance impairs hippocampal neurogenesis, reduces BDNF expression, and accelerates amyloid-beta accumulation. The same PI3K/Akt pathway that CocoaNol® targets for NO production is also the central insulin signaling pathway — making insulin sensitivity a shared metabolic-cognitive mechanism.
The Glycemic Tightrope
Both hyperglycemia and hypoglycemia impair cognition through different mechanisms: hyperglycemia promotes oxidative stress and AGE formation; hypoglycemia starves neurons of their primary fuel. Insulin sensitizers like Ceylon cinnamon help narrow the glycemic range — keeping brain glucose delivery in the optimal window for sustained cognitive output.
How Ceylon Cinnamon Works
Ceylon cinnamon (Cinnamomum verum) contains a distinct phytochemical profile — primarily Type-A procyanidins and cinnamaldehyde — that exerts insulin-sensitizing effects through AMPK activation and insulin receptor pathway enhancement. The 10:1 extract in APEX delivers concentrated active compounds equivalent to 3,000 mg of raw bark at a 300 mg dose.
AMPK Activation
Ceylon cinnamon’s polyphenols activate AMP-activated protein kinase (AMPK) — the cellular energy sensor that promotes GLUT4 translocation to the cell membrane. GLUT4 is the primary glucose transporter in skeletal muscle and adipose tissue — its surface expression directly determines insulin-independent glucose uptake capacity. AMPK activation mimics an exercise-like metabolic state.
Insulin Receptor Sensitization
Cinnamon-derived procyanidins enhance insulin receptor substrate (IRS-1) phosphorylation and downstream PI3K/Akt signaling. This sensitizes cells to circulating insulin, reducing the amount of insulin required for glucose clearance — effectively reducing postprandial insulin spikes alongside glucose spikes. Lower insulin volatility improves the metabolic stability that cognitive performance depends on.
Alpha-Amylase and Alpha-Glucosidase Inhibition
Cinnamaldehyde and Type-A procyanidins inhibit carbohydrate-digesting enzymes in the small intestine — slowing the rate of glucose release from dietary starch. This blunts the postprandial glucose spike at its source, flattening the glycemic curve independently of insulin signaling. The result is a slower, more sustained glucose delivery to the brain.
Antioxidant and Anti-Inflammatory Protection
Ceylon cinnamon’s polyphenol content provides direct antioxidant protection against the oxidative stress generated by glycemic spikes. Hyperglycemia generates advanced glycation end products (AGEs) and activates NF-κB inflammatory pathways. Cinnamon polyphenols scavenge free radicals and reduce AGE formation — protecting neurons and blood vessels from the glycation damage that accumulates with chronic blood sugar volatility.
What the Research Shows
Ceylon cinnamon is supported by randomized, controlled trials and meta-analyses demonstrating significant reductions in fasting glucose, HbA1c, and cholesterol across multiple populations.
Khan et al. (2003). Diabetes Care, 26(12):3215-3218. 1, 3, or 6g cinnamon/day for 40 days in type 2 diabetics. Significant reductions in fasting glucose, triglycerides, LDL, and total cholesterol.
Allen, R. W., Schwartzman, E., Baker, W. L., Coleman, C. I., & Phung, O. J. (2013). Cinnamon use in type 2 diabetes: An updated systematic review and meta-analysis. Annals of Family Medicine, 11(5), 452–459.
Ranasinghe, P., Pigera, S., Premakumara, G. A., Galappaththy, P., Constantine, G. R., & Katulanda, P. (2013). Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complementary and Alternative Medicine, 13, 275.
Your Daily Dose in APEX
Why this dose works: APEX uses Ceylon cinnamon specifically — not Cassia — for the safety profile. Cassia cinnamon contains 0.5–1% coumarin (a hepatotoxin), limiting safe daily intake to small amounts. Ceylon contains ~250x less coumarin, enabling sustained daily supplementation at effective doses without hepatotoxic risk. The 10:1 extract concentration allows clinical-range active compound delivery in a 300 mg capsule dose.
How Ceylon Cinnamon Connects Across the System
Ceylon cinnamon is the glycemic stability anchor in APEX — supporting the metabolic foundation that the stimulatory, perfusion, and neuroplasticity stacks require. Blood sugar volatility is an invisible tax on every downstream cognitive mechanism.
Dual Glycemic Control
Ceylon cinnamon activates AMPK and sensitizes the insulin receptor. CocoaNol® improves PI3K/Akt signaling — the downstream effector of both the insulin receptor and eNOS activation. Both operate on overlapping metabolic pathways. Desideri et al. (2012) demonstrated that insulin resistance mediated cocoa’s cognitive benefits in MCI subjects — meaning the Ceylon + CocoaNol® combination addresses glycemic control through two independent inputs into a shared mechanism.
Dual-Fuel Insurance
Glucose and oxygen are the two rate-limiting fuels for cognitive performance. NooLVL® + CocoaNol® address oxygen delivery via NO-mediated cerebral blood flow. Ceylon cinnamon addresses glucose delivery stability by flattening postprandial spikes and reducing reactive dips. Di-Magnesium Malate provides Krebs cycle substrate for mitochondrial ATP production. Together, these ingredients form a complete metabolic foundation: stable glucose + enhanced oxygen delivery + mitochondrial energy substrate.
Insulin Sensitivity → Cognitive Benefit
Ceylon cinnamon improves daytime insulin sensitivity, reducing postprandial glucose volatility during the cognitive performance window. Overnight, RESET’s magnesium supports insulin signaling pathways (magnesium is required for insulin receptor autophosphorylation). Better overnight insulin sensitivity means lower fasting glucose the next morning — a compounding metabolic benefit across the circadian cycle.
Key Takeaways
Blood Sugar Stability Is a Cognitive Performance Input
Postprandial glucose spikes followed by reactive dips measurably impair working memory and sustained attention. Ceylon cinnamon flattens the glycemic curve — narrowing the glucose range that the brain operates within during peak performance hours.
Ceylon vs. Cassia: The Safety Distinction
Cassia cinnamon contains coumarin at levels that limit safe daily intake. Ceylon cinnamon contains ~250x less coumarin, enabling chronic daily supplementation at clinically effective doses. APEX uses only Ceylon — no hepatotoxic risk, full metabolic benefit.
AMPK: The Exercise-Mimicking Pathway
AMPK activation by cinnamon polyphenols drives GLUT4 translocation to the cell surface — the same mechanism triggered by aerobic exercise. This promotes insulin-independent glucose uptake, providing metabolic benefit even in insulin-resistant states.
Shared Pathway with CocoaNol®
Both Ceylon cinnamon and CocoaNol® converge on the PI3K/Akt signaling pathway — cinnamon through insulin receptor sensitization, CocoaNol® through eNOS activation and endothelial insulin signaling. This creates metabolic redundancy: two independent inputs into one shared mechanism governing both blood sugar control and cerebral blood flow.
Frequently Asked Questions
What is the difference between Ceylon and Cassia cinnamon?
Ceylon cinnamon (Cinnamomum verum) and Cassia cinnamon (Cinnamomum cassia) are different species. Cassia contains 0.5–1% coumarin, a compound that is hepatotoxic at high daily doses. Ceylon contains approximately 250x less coumarin, making it safe for sustained daily supplementation at clinically effective doses. APEX uses only Ceylon cinnamon.
How does blood sugar stability affect cognitive performance?
The brain consumes approximately 120 g of glucose per day — 20% of total body production. Postprandial glucose spikes followed by reactive dips create a rollercoaster effect that impairs working memory, sustained attention, and processing speed. Ceylon cinnamon helps narrow the glycemic range, providing steadier fuel delivery to the brain.
What is the APEX dose equivalent to?
APEX delivers 300 mg of 10:1 Ceylon cinnamon extract per serving, equivalent to approximately 3,000 mg of raw bark in active compound concentration. This provides clinical-range polyphenol and cinnamaldehyde content in a single capsule dose.
Is the coumarin content in APEX safe?
The estimated coumarin content per APEX serving is approximately 0.003 mg — far below the European Food Safety Authority’s tolerable daily intake of 0.1 mg/kg body weight (7 mg for a 70 kg adult). Ceylon cinnamon is specifically chosen for this safety profile.
Does Ceylon cinnamon work for people without diabetes?
Yes. The insulin-sensitizing and enzyme-inhibiting effects of Ceylon cinnamon apply to anyone who consumes carbohydrates. Even in healthy individuals, postprandial glucose spikes impair cognitive performance. Ceylon cinnamon flattens the glycemic curve during the morning performance window regardless of diabetic status.
How does Ceylon cinnamon interact with the other APEX ingredients?
Ceylon cinnamon and CocoaNol® both converge on the PI3K/Akt signaling pathway — cinnamon through insulin receptor sensitization, CocoaNol® through eNOS activation. This creates metabolic redundancy: two independent inputs into one shared mechanism governing both blood sugar control and cerebral blood flow.
References
- [1]Khan, A., Safdar, M., Ali Khan, M. M., Khattak, K. N., & Anderson, R. A. (2003). Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care, 26(12), 3215–3218.View
- [2]Allen, R. W., Schwartzman, E., Baker, W. L., Coleman, C. I., & Phung, O. J. (2013). Cinnamon use in type 2 diabetes: An updated systematic review and meta-analysis. Annals of Family Medicine, 11(5), 452–459.View
- [3]Ranasinghe, P., Pigera, S., Premakumara, G. A., Galappaththy, P., Constantine, G. R., & Katulanda, P. (2013). Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complementary and Alternative Medicine, 13, 275.View
Upgrade Your Metabolic Stability
Ceylon Cinnamon is one of 28 active ingredients in APEX, engineered to work as a system — not a stack of standalone compounds.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.